We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




AI Model Provides Real-Time Sepsis Risk Alerts for Improving ICU Patient Survival

By HospiMedica International staff writers
Posted on 27 Mar 2025

Sepsis is a leading cause of death in intensive care units (ICUs), caused by an overwhelming response to infection in the body. More...

Despite advancements in medical treatment, its in-hospital mortality rate remains alarmingly high, ranging from 20% to 50%. The difficulty lies in identifying sepsis early, as it is a highly dynamic condition, and existing scoring systems such as APACHE-II and SOFA are not specifically designed to track its rapid progression. Although machine learning has shown promise in sepsis prediction, most models fail to account for real-time fluctuations in patient data. This highlights the need for a more advanced predictive system that can continuously learn from incoming clinical data to improve early detection and outcomes for patients.

Researchers from Sichuan University (Chengdu, China) and their collaborators have developed a two-stage transformer-based model aimed at predicting ICU sepsis mortality. The model was trained on data from the eICU Collaborative Research Database, which includes over 200,000 patient records, and processes both hourly and daily health indicators. By day five of ICU admission, the model achieved an impressive AUC of 0.92, significantly outperforming traditional scoring systems like APACHE-II. This AI-driven model represents a major step forward in sepsis prediction. It operates in two stages: the first analyzes hourly data to capture critical intra-day changes in vital signs and lab results, while the second stage incorporates daily data to identify longer-term trends. This dual approach enables the model to adjust to the rapid fluctuations characteristic of sepsis.

The study, published in Precision Clinical Medicine, showed that key mortality predictors—such as lactate levels, respiratory rates, and coagulation markers—were identified with high accuracy. A key innovation of the model is its ability to generate real-time risk alerts, providing ICU teams with actionable insights at the most critical moments. The inclusion of SHAP (SHapley Additive exPlanations) visualizations ensures that the model’s predictions are interpretable, allowing clinicians to understand which factors influence the predictions. Additionally, the model demonstrated robustness when validated on external datasets, including patient cohorts from China and the MIMIC-IV database. This research has the potential to transform ICU management. By integrating the AI model into hospital information systems, clinicians could receive daily risk alerts, enabling earlier and more focused interventions.

The model’s ability to adapt across different patient populations and its resilience to missing data make it a valuable tool in a variety of healthcare settings around the world. Future advancements may see the model incorporated into real-time monitoring systems, continuously updating risk scores and reducing diagnostic delays. Beyond its immediate clinical applications, the model’s interpretability through SHAP analysis provides deeper insights into the progression of sepsis, potentially guiding the development of targeted therapies. This breakthrough not only improves patient care but also sets a new standard for AI-driven predictive models in critical care medicine. With its ability to process vast amounts of real-time data and turn it into life-saving insights, this AI tool has the potential to redefine the standard of care for sepsis patients, enabling timely interventions and improving survival rates on a global scale.


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.